Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (408)	1/24/2001 2:57:50 PM
From: tuck	Read Replies (1) \| Respond to of 1784

Thanks, Rick, Wondering about this XGEN news you posted. Because it looks like old news recycled. XGEN already had a commercial deal with Pfizer, and this looks no different on the face of it. Hype machine in action? Meanwhile, a couple of trickle news tidbits. ABI & A sign a deal, but are mum on the terms. The secrecy isn't slowing down ABI's stock price, though. biz.yahoo.com And PBSC says some more about its intentions in the microarray biz. To clarify an earlier post, they are getting out of the DNA chip biz, but staying with protein chip and microarray businesses. biz.yahoo.com Trickle flirting with positive territory again, but I'm not super optimistic about it holding, near-term. Market looking toppy to me. Cheers, Tuck